BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%

MT Newswires Live

Mar 13

BlinkLab (ASX:BB1) partnered with the US-based SHANK2 Foundation to support the expansion of its digital neurodiagnostic platform into neurodevelopmental disorders and rare disease research, according to a Friday filing with the Australian bourse.

The partnership gives the company access to a genetically defined patient population, allowing for the validation of its digital biomarkers in a biologically well-characterized neurodevelopmental disorder, the filing said.

The foundation is a non-profit organization focused on improving awareness and research infrastructure for rare neurodevelopmental conditions linked to mutations or deletions in the SHANK2 gene, per the filing.

BlinkLab shares rose 3% in midday trade on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2619155072"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2619155072\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2619155072?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619155072","market":"nz","top_or_hot":-1,"title":"BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> BlinkLab (ASX:BB1) partnered with the US-based SHANK2 Foundation to support the expansion of its digital neurodiagnostic platform into neurodevelopmental disorders and rare disease research, according to a Friday filing with the Australian bourse.</p><p>The partnership gives the company access to a genetically defined patient population, allowing for the validation of its digital biomarkers in a biologically well-characterized neurodevelopmental disorder, the filing said.</p><p>The foundation is a non-profit organization focused on improving awareness and research infrastructure for rare neurodevelopmental conditions linked to mutations or deletions in the SHANK2 gene, per the filing.</p><p>BlinkLab shares rose 3% in midday trade on Friday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlinkLab Partners With US-Based Non-Profit Organization; Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-13 09:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BlinkLab (ASX:BB1) partnered with the US-based SHANK2 Foundation to support the expansion of its digital neurodiagnostic platform into neurodevelopmental disorders and rare disease research, according to a Friday filing with the Australian bourse.</p><p>The partnership gives the company access to a genetically defined patient population, allowing for the validation of its digital biomarkers in a biologically well-characterized neurodevelopmental disorder, the filing said.</p><p>The foundation is a non-profit organization focused on improving awareness and research infrastructure for rare neurodevelopmental conditions linked to mutations or deletions in the SHANK2 gene, per the filing.</p><p>BlinkLab shares rose 3% in midday trade on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2619155072","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619155072","pubTimestamp":1773366194,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BlinkLab  partnered with the US-based SHANK2 Foundation to support the expansion of its digital neurodiagnostic platform into neurodevelopmental disorders and rare disease research, according to a Friday filing with the Australian bourse.The partnership gives the company access to a genetically defined patient population, allowing for the validation of its digital biomarkers in a biologically well-characterized neurodevelopmental disorder, the filing said.The foundation is a non-profit organization focused on improving awareness and research infrastructure for rare neurodevelopmental conditions linked to mutations or deletions in the SHANK2 gene, per the filing.BlinkLab shares rose 3% in midday trade on Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","BB1.AU":"Blinklab Ltd"},"translate_title":"BlinkLab与美国非营利组织合作；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BB1.AU":1},"content_text":"BlinkLab (ASX:BB1) partnered with the US-based SHANK2 Foundation to support the expansion of its digital neurodiagnostic platform into neurodevelopmental disorders and rare disease research, according to a Friday filing with the Australian bourse.The partnership gives the company access to a genetically defined patient population, allowing for the validation of its digital biomarkers in a biologically well-characterized neurodevelopmental disorder, the filing said.The foundation is a non-profit organization focused on improving awareness and research infrastructure for rare neurodevelopmental conditions linked to mutations or deletions in the SHANK2 gene, per the filing.BlinkLab shares rose 3% in midday trade on Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}